Results: argenx SE Confounded Analyst Expectations With A Surprise Profit
Jul 29
Belgian (BEL20) Biotech Industry Analysis
UpdatedJul 29, 2024
DataAggregated Company Financials
Companies3
- 7D5.5%
- 3M28.6%
- 1Y-1.2%
- YTD30.7%
In the last week, the Biotech industry is up 5.5%, with argenx up 7.3%. During this same period, the MDxHealth underperformed, falling 5.6%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 59% annually.
Industry Valuation and Performance
Has the Belgian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 Jul 2024 | €27.0b | €1.6b | -€197,358,745.00 | n/a | -137x | 17.2x |
| Thu, 27 Jun 2024 | €25.0b | €1.4b | -€316,056,477.70 | n/a | -79.1x | 17.8x |
| Sat, 25 May 2024 | €20.1b | €1.4b | -€311,439,904.30 | n/a | -64.6x | 14.6x |
| Mon, 22 Apr 2024 | €20.1b | €1.2b | -€286,292,251.10 | n/a | -70.1x | 16.3x |
| Wed, 20 Mar 2024 | €19.7b | €1.2b | -€303,063,781.20 | n/a | -65.1x | 16.4x |
| Fri, 16 Feb 2024 | €21.6b | €994.8m | -€249,227,464.50 | n/a | -86.7x | 21.7x |
| Sun, 14 Jan 2024 | €20.6b | €1.0b | -€286,628,122.00 | n/a | -71.8x | 19.8x |
| Tue, 12 Dec 2023 | €24.8b | €1.1b | -€291,343,744.00 | n/a | -85.2x | 23.5x |
| Thu, 09 Nov 2023 | €27.7b | €1.1b | -€295,464,663.00 | n/a | -93.8x | 26.4x |
| Sat, 07 Oct 2023 | €27.5b | €880.4m | -€451,650,334.00 | n/a | -60.9x | 31.2x |
| Mon, 04 Sep 2023 | €28.1b | €863.9m | -€459,766,168.00 | n/a | -61.2x | 32.5x |
| Wed, 02 Aug 2023 | €27.2b | €840.3m | -€451,698,684.00 | n/a | -60.2x | 32.4x |
| Fri, 30 Jun 2023 | €19.8b | €667.4m | -€560,629,916.00 | n/a | -35.4x | 29.7x |
| Sun, 28 May 2023 | €21.0b | €675.7m | -€567,390,937.00 | n/a | -37x | 31.1x |
| Tue, 25 Apr 2023 | €19.8b | €452.6m | -€724,497,666.00 | n/a | -27.3x | 43.7x |
| Thu, 23 Mar 2023 | €18.6b | €462.1m | -€724,198,698.00 | n/a | -25.7x | 40.4x |
| Sat, 18 Feb 2023 | €19.4b | €314.8m | -€914,077,115.00 | n/a | -21.2x | 61.5x |
| Mon, 16 Jan 2023 | €20.7b | €310.5m | -€896,570,825.00 | n/a | -23.1x | 66.7x |
| Wed, 14 Dec 2022 | €20.5b | €316.2m | -€913,744,255.00 | n/a | -22.5x | 65x |
| Fri, 11 Nov 2022 | €20.7b | €329.7m | -€954,035,761.00 | n/a | -21.7x | 62.7x |
| Sun, 09 Oct 2022 | €20.4b | €193.7m | -€988,454,907.00 | n/a | -20.7x | 105.4x |
| Tue, 06 Sep 2022 | €21.3b | €172.2m | -€974,418,400.00 | n/a | -21.8x | 123.6x |
| Thu, 04 Aug 2022 | €20.2b | €167.3m | -€951,171,831.00 | n/a | -21.2x | 120.6x |
| Sat, 02 Jul 2022 | €20.0b | €388.9m | -€627,324,232.00 | n/a | -31.9x | 51.4x |
| Mon, 30 May 2022 | €16.6b | €377.5m | -€609,793,208.00 | n/a | -27.2x | 43.9x |
| Wed, 27 Apr 2022 | €16.5b | €516.6m | -€436,843,353.00 | n/a | -37.8x | 31.9x |
| Fri, 25 Mar 2022 | €15.1b | €500.4m | -€414,892,703.00 | n/a | -36.5x | 30.3x |
| Sun, 20 Feb 2022 | €13.1b | €468.3m | -€401,857,819.00 | n/a | -32.5x | 27.9x |
| Tue, 18 Jan 2022 | €13.6b | €465.2m | -€399,532,890.00 | n/a | -33.9x | 29.2x |
| Thu, 16 Dec 2021 | €14.1b | €471.1m | -€404,022,408.00 | n/a | -35x | 30x |
| Sat, 13 Nov 2021 | €14.2b | €463.6m | -€396,334,256.00 | n/a | -35.9x | 30.7x |
| Mon, 11 Oct 2021 | €13.4b | €465.3m | -€362,130,149.00 | n/a | -37.1x | 28.9x |
| Wed, 08 Sep 2021 | €14.8b | €454.2m | -€354,561,673.48 | n/a | -41.8x | 32.6x |
| Fri, 06 Aug 2021 | €13.8b | €453.0m | -€354,165,121.68 | n/a | -39x | 30.5x |
Price to Earnings Ratio
-39x
Current Industry PE
- There are only 3 companies in the Belgian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 51% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare industry?
| BE Market | 1.01% | |
| Healthcare | 5.26% | |
| Biotech | 5.48% | |
| Biotech | 5.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARGX argenx | €459.10 | 7.3% +€1.9b | 0.5% | PS17.9x |
